These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 34066560)

  • 1. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
    Ailioaie LM; Litscher G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
    Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.
    Lee E; Hong SJ
    Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):245-251. PubMed ID: 33769313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in Medicine: A Long Debate.
    Stavropoulou E; Bezirtzoglou E
    Front Immunol; 2020; 11():2192. PubMed ID: 33072084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
    Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
    Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.
    Ahmadi Badi S; Tarashi S; Fateh A; Rohani P; Masotti A; Siadat SD
    Mediators Inflamm; 2021; 2021():6611222. PubMed ID: 33953641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and Coronavirus disease 2019: think about the link.
    Angurana SK; Bansal A
    Br J Nutr; 2021 Nov; 126(10):1564-1570. PubMed ID: 32921328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
    Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
    Front Immunol; 2020; 11():607734. PubMed ID: 33569053
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-talk between immune system and microbiota in COVID-19.
    Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Probiotics in the Management of COVID-19: A Computational Perspective.
    Nguyen QV; Chong LC; Hor YY; Lew LC; Rather IA; Choi SB
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
    Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
    Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiota-A Promising Target for Antiviral Therapy?
    Yang M; Yang Y; He Q; Zhu P; Liu M; Xu J; Zhao M
    Front Immunol; 2021; 12():676232. PubMed ID: 34054866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.
    Hussain I; Cher GLY; Abid MA; Abid MB
    Front Immunol; 2021; 12():765965. PubMed ID: 34721437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiota-mediated dietary and nutritional interventions for COVID-19.
    Gasmi A; Tippairote T; Mujawdiya PK; Peana M; Menzel A; Dadar M; Benahmed AG; Bjørklund G
    Clin Immunol; 2021 May; 226():108725. PubMed ID: 33845194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and Covid-19.
    Bottari B; Castellone V; Neviani E
    Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications.
    Pandey M; Bhati A; Priya K; Sharma KK; Singhal B
    Probiotics Antimicrob Proteins; 2022 Jun; 14(3):426-448. PubMed ID: 34806151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral Infections, the Microbiome, and Probiotics.
    Harper A; Vijayakumar V; Ouwehand AC; Ter Haar J; Obis D; Espadaler J; Binda S; Desiraju S; Day R
    Front Cell Infect Microbiol; 2020; 10():596166. PubMed ID: 33643929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection.
    Spagnolello O; Pinacchio C; Santinelli L; Vassalini P; Innocenti GP; De Girolamo G; Fabris S; Giovanetti M; Angeletti S; Russo A; Mastroianni CM; Ciccozzi M; Ceccarelli G; d'Ettorre G
    Chemotherapy; 2021; 66(1-2):24-32. PubMed ID: 33756475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
    Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
    Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.